Navigation Links
BMP Sunstone Announces Participation in May Investor Conferences
Date:5/16/2008

PLYMOUTH MEETING, Pa., May 16 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) one of China's leading marketing and distribution pharmaceutical companies, today announced that the Company will present at the following conferences:

(1) The Roth Annual China Discovery Tour held in seven cities in China.

David Gao, Chief Executive Officer of the Company, is currently

scheduled to present on May 19, 2008, at 4:40 pm local time at the

Regent Hotel in Beijing;

(2) The Credit Suisse healthcare tour in China. Mr. Gao is currently

scheduled to present on May 22, 2008 at 4:00 pm local time at the

Grand Hyatt Hotel in Beijing;

(3) The Oppenheimer China Dragon Call Conference held in its New York

office. Management is currently scheduled to present on May 22, 2008,

at 12:55 pm ET and hold one-on-one meetings the same day. Listeners

may access a live webcast of the presentation by visiting the investor

relations portion of the Company's website at

http://www.bmpsunstone.com ; and

(4) The UBS Global Specialty and Generic Pharmaceutical Conference held on

May 28 and 29, 2008, at the Waldorf Hilton Hotel in London.

Investors interested in attending these events should contact their institutional sales representatives.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BMP Sunstone to Report First Quarter 2008 Financial Results
2. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
3. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
4. Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula
5. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
6. Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
7. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
8. Tempo Participacoes Announces Increase of 34% in EBITDA and of 25% in Net Revenue for the 1Q08
9. LifeCare Holdings, Inc. Announces First Quarter Results
10. QLT Inc. announces agreement for sale of real estate
11. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., VIENNA, Va., Jan. 8 The Nationa...Inc., today announced the results of its organizat...on, President and CEO of Prematics, Inc., was elec...009 Board of Directors. The Collaborative builds ...rmation Community (AHIC), a federal advisory commi...
(Date:1/8/2009)..., , , Kelly Ripa Will Be Celebrity Host of S...Newswire/ -- Stand Up for a Cure today announced...ne,s Day show with Barry Manilow , in partnership... , The show will be held on February 14th, 2009 a...event go on sale Monday November 10th through Tick...
(Date:1/8/2009)..., WASHINGTON, Jan. 8 T...ability to plan and prepare for expensive long-ter...g to a new survey released today by America,s Heal...by StrategyOne on behalf of AHIP, found that 60 pe...ability to plan for future long-term care costs. ...
(Date:1/8/2009)...esearchers find it prolongs lives of key vision ce...Day News) -- Researchers working with mice have id...es of retinal cells in both healthy and diseased e...tments that would prevent blindness among people g... the scientists said. , The protein, known as h...
Breaking Medicine News(10 mins):Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3
...ikerwal, said today that the Government could save...get if it allowed GPs to refer patients directly f... of the proposal are contained in the AMA's Federa..., which was released yesterday. Dr Haikerwal sai...
...e banned from adding trans fatty acids to any food...aikerwal, said today. // 'The AMA believes the add...d out completely,' Dr Haikerwal said. 'In the mea...at have had trans fatty acids added to them should...
...men strongly about the side effects associated wit...er off //the development of severe blood clots in...ethinyl estradiol is available in the U.S with mor... in Canada. Use of this birth control patch has be...
...chool of Medicine have reported that genetics has ...rity (ROP) in preemies//, a disease known to hampe...nd could cause blindness. This report is published...“This is the first definitive study to show that g...
Other Medicine News:Health News:Genetics Plays A Crucial Role In Preemies' Destructive Eye Disease 2
(Date:1/8/2009)...rk,s second indication with clinical-stage, system..., FREMONT, Calif., Jan. 8 Quark Ph...tical company discovering and developing novel RNA...ounced that it has initiated patient dosing in its...ally administered siRNA drug candidate QPI-1002 (p...
(Date:1/8/2009)...Validate Novel Gene Expression Biomarkers Involved...Platform , , FREMONT, Calif., Jan. 8 /PRNewswir...letin Board: WGBS), a leading developer of state-o...y and stem cell research systems, today announced ...University of Texas Southwestern Medical Center f...
(Date:1/8/2009)... -- If you are taking prescription medicine,and f...the people taking,prescription medicine don,t tak...y forget, are busy with other priorities, or make ...en called the Achilles heel of modern,healthcare.... "Drugs don,t,work in people who don,t take them....
(Date:1/8/2009)...hio, Jan. 8 IntelligentMDx a develo...ssays, today announced that verification studies o...re complete. , , Under the verification protoc...and reproducibility and robustness of the BK Viral...in agreed with internally generated analytical per...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 1Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 2Solar flares set the Sun quaking 2957 1Solar flares set the Sun quaking 2957 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 1HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 3Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 1Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 3
...and BASEL, Switzerland, June 27 /CNW/ -,Aspreva Ph... and,Roche today released preliminary results for ...olate mofetil, MMF) to intravenous,cyclophosphamid...r,inducing treatment response in the induction pha...though response rates were similar in both arms, t...
...IRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT)...reclinical,data that support the safety, activity,...brotide in combination with anticancer,therapy in ...update,from the Company,s ongoing Phase I/II clini... multiple myeloma with Defibrotide in,combination ...
Other Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads.
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy.
...g device for finger and alternate site testing fro... Comfort Zone Technology and Force Adjustment that... Comfort Zone Technology increases comfort when la... pain. This approach masks the pain of lancing to ...
Reduce the pain and hassle of testing. Unlike conventional lancing systems, the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing, with les
Medicine Products: